NCT01951404View on ClinicalTrials.gov

Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
End Stage Renal DiseaseLeft Ventricular Hypertrophy
Interventions
DRUG

Allopurinol

DRUG

Placebo (for allopurinol)

Trial Locations (3)

G12 8TA

NHS Greater Glasgow and Clyde, Glasgow

DD9 1SY

NHS Tayside, Dundee

KA2OBE

NHS Ayrshire and Arran, Crosshouse

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

collaborator

NHS Tayside

OTHER_GOV

collaborator

NHS Greater Glasgow and Clyde

OTHER

collaborator

University of Glasgow

OTHER

lead

University of Dundee

OTHER

NCT01951404 - Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study | Biotech Hunter | Biotech Hunter